This is the text extract for 2011-04 Schedule Dispatch , browse documents here.

---

17 March 2011 April 2011 Pharmaceutical Schedule Dispatch This document is provided to pharmacists as an early notification of the changes to be announced in the April 2011 Update to the Pharmaceutical Schedule. Please notify PHARMAC (0800 66 00 50) to change or remove your contact details. New listings  Metoprolol succinate (Myloc CR) tab long-acting 23.75 mg (p’code 2376415), 47.5 mg (p’code 2376423), 95 mg (p’code 2376431) and 190 mg (p’code 2376458)  Etanercept (Enbrel) inj 50 mg prefilled syringe – Special Authority – Retail Pharmacy (p’code 2382113)  Sumatriptan (Arrow-Sumatriptan) inj 12 mg per ml, 0.5 ml, 2 OP – Retail Pharmacy – Specialist, maximum of 10 inj per prescription (p’code 2381656)  Naltrexone hydrochloride (Naltraccord) tab 50 mg – Special Authority – Retail pharmacy (p’code 2380374)  Nicotine (Habitrol) lozenge 1 mg, 216 pack (p’code 2381370), 2 mg, 216 pack (p’code 2381362), and patch 7 mg, 28 pack (p’code 2381389), 14 mg, 28 pack (p’code 2381397), 21 mg, 28 pack (p’code 2381400) – will not be funded Close Control in amounts less than 4 weeks  Thalidomide (Thalomid) cap 50 mg – PCT only – Specialist – Special Authority – Only on a controlled drug form (p’code 2381125)  Ipratropium bromide (Univent) aqueous nasal spray 0.03%, 15 ml OP (p’code 2372908) New Brand Switch Payments  Pharmacy services (BSF m-Captopril) brand switch fee – no patient co-payment payable – may only be claimed once per patient per fee (p’code 2378647)

The above Pharmacode corresponds with the Brand Switch payments listed as part of the 2010 Pharmacy Services Contract. Full details on dispensing Brand Switch payments, along with resources to aid pharmacists in explaining brand switches were sent to pharmacies in late October 2010. For further resources please order from www.pharmaconline.co.nz. For more information in the meantime, visit: http://www.pharmac.govt.nz/2010/10/17

Changes to restrictions  Lincomycin (Lincocin) inj 300 mg per ml, 2 ml vial – removal of Section 29  Adalimumab inj 40 mg per 0.8 ml prefilled pen (HumiraPen) and inj 40 mg per 0.8 ml prefilled syringe (Humira) – amended Special Authority criteria  Etanercept (Enbrel) inj 25 mg, inj 50 mg autoinjector, inj 50 mg prefilled syringe – amended Special Authority criteria  Varenicline tartrate (Champix) tab 1 mg, and tab 0.5 mg x 11 and 1 mg x 14 – will not be funded Close Control in amounts less than 2 weeks of treatment  Exemestane (Aromasin) tab 25 mg – removal of Special Authority criteria SPECIAL FOODS From 1 April 2001 there will be a number of changes to the access and funding of special foods. The changes are as follows:  Delisting of Karicare Goats Milk Infant Formula, Delact lactose free infant formula, S26 Soy soya infant formula, and Karicare Soy All Ages infant soy formula.  The various brands of Pepti Junior, Elecare and Neocate will be fully subsidised.  New Special Authority criteria for ‘Standard Supplements’.  The subsidy for the standard ready-mixed oral feed 1.5kcal/ml with and without fibre (Fortisip, Ensure Plus and Fortisip Multi Fibre) and 2.0 kcal/ml liquids (Two Cal HN) will be reduced to the level of the subsidy for oral feed 1 kcal/ml powder (Ensure and Sustagen Hospital Formula) via the application of reference pricing. Those patients

A412954 - qA19569 Page 1 of 3

---



     

       

with existing Special Authority approvals do not need to reapply for new approvals until their current approval expires. Existing Special Authorities for ready-mixed oral feed are interchangeable with powders. Repeats for standard ready-mixed oral feed 1.5kcal/ml with and without fibre (Fortisip, Ensure Plus 237 ml OP and Fortisip Multi Fibre) and 2.0 kcal/ml liquids (Two Cal HN) will be fully subsidised where the initial dispensing was before 1 April 2011. Nutricia has increased the price of Fortisip and Fortisip Multi Fibre which will increase the patient part charge on these products. Gluten free foods will no longer be actively managed by PHARMAC (no new listings or subsidy changes). New Special Authority criteria without renewal for ‘Foods and Supplements for Inborn Errors of Metabolism.’ Increased subsidy for all brands of low protein baking mix and low protein pasta. PHARMAC and bpacNZ are producing patient information leaflets. These will be distributed when available. Special Foods Special Authority applicant types extended to a relevant specialist or vocationally registered general practitioner. Reapplications from a relevant specialist, vocationally registered general practitioner or general practitioner on the recommendation of a relevant specialist or vocationally registered general practitioner Diabetic Products (Diason RTH, Glucerna Select RTH, Diasip, Glucerna Select and Resource Diabetic) liquid – amended Special Authority criteria Removal of distinction between use of special foods as a supplement or as a complete diet. “Oral Supplements” and “Adult Products Standard” groups replaced with “Standard Supplements” with new Special Authority criteria Foods and Supplements for Inborn Errors of Metabolism – amended Special Authority criteria and removal of Prescribing Guideline Low protein baking mix (Loprofin Mix) powder – change in chemical name from phenyl free baking mix Low protein pasta (Loprofin) – change in chemical name from phenyl free pasta Gastrointestinal and Other Malabsorptive Problems – removal of Prescribing Guideline Elemental Formula separated into “Extensively Hydrolysed Formula” and “Amino Acid Formula”, with separate Special Authority criteria

Decreased subsidy Chemical Amino acid formula Amitriptyline Doxazosin mesylate Exemestane Isosorbide mononitrate Oral feed 1.5kcal/ml Presentation Powder, 400 g OP Tab 25 mg Tab 50 mg Tab 2mg Tab 4 mg Tab 25 mg Tab 20 mg Tab long-acting 40 mg Liquid (banana) 200 ml OP Liquid (chocolate) 200 ml OP 237 ml OP Liquid (coffee latte) 237 ml OP Liquid (fruit of the forest) 200 ml OP A412954 - qA19569 Fully subsidised brands Neocate Neocate LCP Amitrip Amitrip Apo-Doxazosin Apo-Doxazosin Aromasin Ismo 20 Corangin Fortisip Ensure Plus Fortisip Ensure Plus Ensure Plus Ensure Plus Ensure Plus Page 2 of 3 Partially subsidised brands

---

Liquid (strawberry) 200 ml OP 237 ml OP Liquid (toffee) 200 ml OP Liquid (tropical fruit) 200 ml OP Liquid (vanilla) 200 ml OP 237 ml OP Liquid (chocolate), 200 ml OP Liquid (strawberry), 200 ml OP Liquid (vanilla), 200 ml OP Liquid (vanilla), 237 ml OP Tab 10 mg Tab 20 mg

Oral feed with fibre 1.5kcal/ml Oral Feed 2kcal/ml Metoclopramide hydrochloride Tamoxifen citrate

Fortisip Ensure Plus Ensure Plus Fortisip Fortisip Fortisip Ensure Plus Ensure Plus Fortisip Multi Fibre Fortisip Multi Fibre Fortisip Multi Fibre Two Cal HN Metamide Genox

Increased subsidy

Chemical Amino acid formula Presentation Powder 48.5 g OP Powder (tropical) 400 g OP Powder (unflavoured) 400 g OP Fully subsidised brands Vivonex Pediatric Neocate Advanced Elecare Elecare LCP Neocate Advanced Elecare Myleran Chloromycetin Zarontin Pepti Junior Gold Pepti Junior Florinef Loprofin Mix Loprofin Loprofin Loprofin Loprofin Loprofin Loprofin Loprofin Sotacor Kenacomb

Busulphan Cloramphenicol Ethosuximide Extensively hydrolysed formula Fludrocortisone acetate Low protein baking mix Low protein pasta

Powder (vanilla) 400 g OP Tab 2 mg Ear drop 0.5%, 5 ml OP Oral liq 250 mg per 5 ml, 200 ml Powder, 450 g OP Tab 100 μg Powder, 500 g OP Animal shapes, 500 g OP Lasagne, 250 g OP Low protein rice pasta , 500 g OP Macaroni, 250 g OP Penne, 500 g OP Spaghetti, 500 g OP Spirals, 500 g OP Inj 10 mg per ml, 4 ml Ear drops 1 mg with nystatin 100,000 u, neomycin sulphate 2.5 mg and gramicidin 250 μg per g

Sotalol Triamcinolone acetonide with gramicidin, neomycin and nystatin

NB. For further details and magnitude of the above subsidy changes, please consult the online version of the Update to the Pharmaceutical Schedule at: www.pharmac.govt.nz/healthpros/Schedule.

A412954 - qA19569

Page 3 of 3